Literature DB >> 18528906

Fine-needle aspiration cytology in a regional head and neck cancer center: comparison with a systematic review and meta-analysis.

Sankalap Tandon1, Riad Shahab, James I Benton, Samit K Ghosh, Jonathan Sheard, Terry M Jones.   

Abstract

BACKGROUND: Fine-needle aspiration cytology (FNAC) is used to diagnose masses presenting in the head and neck region. No systematic review of FNAC in this group has yet been performed.
METHODS: A systematic review of the published literature and meta-analysis of data extracted from the included studies were compared with a 10-year review of head and neck FNAC from our institution.
RESULTS: Systematic review identified 30 studies; 3459 FNAC aspirates from all head and neck sites were included. Overall results were as follows: sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) were 89.6%, 96.5%, 93.1%, 96.2%, and 90.3%, respectively. Two thousand seven hundred two head and neck aspirates were included in our institutional review. Sensitivity, specificity, PPV, NPV, and accuracy were 89.5%, 98.5%, 97.3%, 94.0%, and 95.1%, respectively.
CONCLUSION: Meta-analysis and comparative systematic review confirm that FNAC is highly effective in the diagnosis of head and neck masses, with some limitations.

Entities:  

Mesh:

Year:  2008        PMID: 18528906     DOI: 10.1002/hed.20849

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  29 in total

1.  How trustworthy is a diagnosis in head and neck surgical pathology? A consideration of diagnostic discrepancies (errors).

Authors:  Julia A Woolgar; Alfio Ferlito; Kenneth O Devaney; Alessandra Rinaldo; Leon Barnes
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-22       Impact factor: 2.503

2.  CT-guided hookwire placement: a technical innovation for preoperative localization of nonpalpable cervical lymph nodes.

Authors:  J K Hoang; R De Jesus; J D Eastwood; A R Gafton; D L Witsell
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

3.  [Ultrasound-guided minimally invasive diagnostics and treatment in the head and neck area].

Authors:  A Bozzato; C Neubert; Y Yeter
Journal:  HNO       Date:  2021-02       Impact factor: 1.284

4.  Syphilis manifesting as a nasopharyngeal carcinoma with cervical lymphadenopathy: A case report.

Authors:  Xinbin Pan; Xiaodong Zhu; Qingdi Quentin Li
Journal:  Exp Ther Med       Date:  2012-04-02       Impact factor: 2.447

Review 5.  A systematic review of ultrasound-guided FNA of lesions in the head and neck--focusing on operator, sample inadequacy and presence of on-spot cytology service.

Authors:  A Ganguly; G Burnside; P Nixon
Journal:  Br J Radiol       Date:  2014-09-23       Impact factor: 3.039

6.  Simple core-needle biopsy for thyroid nodule, complicated tinnitus.

Authors:  Mathieu Bergeron; Danielle Beaudoin
Journal:  Eur Thyroid J       Date:  2014-06-07

7.  From presumed benign neck masses to delayed recognition of human papillomavirus-positive oropharyngeal cancer.

Authors:  Ruth J Davis; Eleni Rettig; Nafi Aygun; Lisa Rooper; Gypsyamber D'Souza; David W Eisele; Carole Fakhry
Journal:  Laryngoscope       Date:  2019-04-05       Impact factor: 3.325

8.  Parotidectomy and submandibulectomy for benign diseases in Thuringia, Germany: a population-based study on epidemiology and outcome.

Authors:  K Moeller; D Esser; D Boeger; J Buentzel; K Hoffmann; P Jecker; A Mueller; G Radtke; J-U Piesold; S Schultze-Mosgau; M Finkensieper; T Bitter; O Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-17       Impact factor: 2.503

9.  The diagnostic value of fine needle aspiration in parotid lumps.

Authors:  D H Mallon; M Kostalas; F J MacPherson; A Parmar; A Drysdale; E Chisholm; S Sadek
Journal:  Ann R Coll Surg Engl       Date:  2013-05       Impact factor: 1.891

Review 10.  Diffusion-weighted imaging in head and neck cancers.

Authors:  Sanjeev Chawla; Sungheon Kim; Sumei Wang; Harish Poptani
Journal:  Future Oncol       Date:  2009-09       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.